The FDA has approved the Tecnis Symfony IOL for the treatment of cataracts, Abbott announced in a press release. The approval includes the Tecnis Symfony Toric IOL for people with astigmatism.

Toric multifocal IOL now an option for cataract surgery patients The Tecnis Symfony provides a solution for patients with astigmatism.

The TECNIS PC-IOL Portfolio Powered by InteliLight delivers the best* contrast and low-light performance across the PC-IOL category 1,2,3 TECNIS Symfony OptiBlue is now available in the U.S. and ...

The TECNIS Symfony extended range of vision IOL is designed to be placed in the lens capsule of the eye to replace the natural crystalline lens that has been removed because of a cataract.

Abbott announced that the Food and Drug Administration (FDA) has approved the Tecnis Symfony Intraocular Lenses for the treatment of cataracts.

Abbott announced that its pivotal clinical trial of Tecnis Symfony 1-Piece Acrylic Intraocular Lens (IOL) met its primary endpoint of improved intermediate vision. Data from this study showed that ...

– Tecnis Multifocal Acrylic Intraocular lens (Model ZMA00), Tecnis Multifocal 1-Piece Intraocular Lens (Model ZMB00) and Tecnis Silicone Intraocular lens (Model ZM900), manufactured by Abbott Medical ...

After bilateral cataract surgery, patients implanted with multifocal lenses were more likely to be spectacle-independent but also to undergo intraocular lens exchange than those with monofocal lenses.

TECNIS Symfony OptiBlue IOL is powered by InteliLight, an innovative combination of three Johnson & Johnson Vision proprietary technologies: violet-light filter, echelette design and achromatic ...